- Home
- YMAB vs PLBC Comparison
YMAB vs PLBC Comparison
Compare YMAB & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- PLBC
- Stock Information
- Founded
- YMAB 2015
- PLBC 1980
- Country
- YMAB United States
- PLBC United States
- Employees
- YMAB N/A
- PLBC N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- PLBC Finance Companies
- Sector
- YMAB Health Care
- PLBC Finance
- Exchange
- YMAB Nasdaq
- PLBC Nasdaq
- Market Cap
- YMAB 192.4M
- PLBC 236.7M
- IPO Year
- YMAB 2018
- PLBC 2005
- Fundamental
- Price
- YMAB $4.60
- PLBC $43.53
- Analyst Decision
- YMAB Buy
- PLBC Buy
- Analyst Count
- YMAB 11
- PLBC 3
- Target Price
- YMAB $17.55
- PLBC $57.67
- AVG Volume (30 Days)
- YMAB 226.0K
- PLBC 12.1K
- Earning Date
- YMAB 05-13-2025
- PLBC 07-16-2025
- Dividend Yield
- YMAB N/A
- PLBC 2.76%
- EPS Growth
- YMAB N/A
- PLBC 3.33
- EPS
- YMAB N/A
- PLBC 4.95
- Revenue
- YMAB $88,658,000.00
- PLBC $84,001,000.00
- Revenue This Year
- YMAB N/A
- PLBC $19.95
- Revenue Next Year
- YMAB $16.03
- PLBC $22.19
- P/E Ratio
- YMAB N/A
- PLBC $8.80
- Revenue Growth
- YMAB 4.92
- PLBC 9.14
- 52 Week Low
- YMAB $3.55
- PLBC $32.50
- 52 Week High
- YMAB $16.11
- PLBC $51.33
- Technical
- Relative Strength Index (RSI)
- YMAB 56.43
- PLBC 48.47
- Support Level
- YMAB $3.99
- PLBC $43.05
- Resistance Level
- YMAB $5.00
- PLBC $44.84
- Average True Range (ATR)
- YMAB 0.35
- PLBC 1.21
- MACD
- YMAB 0.10
- PLBC -0.22
- Stochastic Oscillator
- YMAB 70.47
- PLBC 13.45
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.